protein
| associating with TBX5 |
|
with PHC1 (role essential for cardiac morphogenesis) |
|
interacting with NKX2-6 (target promoter for its activity) |
|
interacting with other transcription factors such as GATA4 and SRF19 |
|
interacting with DMPK |
|
synergistic interactions between TBX20 and other cardiac transcription factors, including tinman/Nkx2 |
|
5, in regulating cardiac performance, rhythmicity, and cardiomyocyte structure |
|
FBXO25 acts as an ubiquitin E3 ligase to target cardiac transcription factors including NKX2-5, ISL1, and HAND1, indicating that cardiac protein homeostasis through FBXO25 has a pivotal impact on cardiac development |
|
interacting with NPPA (NKX2-5 and its responsive cis-regulatory DNA elements are essential for NPPA expression selectively in the developing heart) |
|
critical role of CITED2 in cardiomyocyte differentiation by affecting the expression of NFATC4 leading to down-regulation of NKX2.5 and beta-MHC cardiomyocyte genes |
|
interaction between NKX2-5 and PPP1R12A (promoting this interaction represents a novel mechanism whereby WNT3A regulates NKX2-5 and inhibits cardiomyogenesis) |
|
NKX2-5 mediates differential cardiac differentiation through interaction with HOXA10 |
|
LRRC10 is a transcriptional target of NKX2-5 and GATA4 |
|
FBXO25 directly interacts with TBX5 and NKX2-5, and controls TBX5 and NKX2-5 transcriptional activity to regulate cardiomyocyte development |
|
plays likely an essential role in cardiomyocyte differentiation by controlling not only transcription but also the nuclear localization of NKX2-5 |